| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-12 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 1e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 8e-06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |